This HTML5 document contains 43 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/mesh/concept/
n17http://linked.opendata.cz/resource/drugbank/drug/DB08796/identifier/wikipedia/
n18http://linked.opendata.cz/resource/drugbank/drug/DB08796/identifier/pharmgkb/
n16http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB08796/identifier/kegg-drug/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08796/identifier/drugbank/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n14http://linked.opendata.cz/ontology/mesh/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08796/identifier/chemspider/
n6http://linked.opendata.cz/resource/atc/
n5http://linked.opendata.cz/ontology/sukl/drug/

Statements

Subject Item
n2:DB08796
rdf:type
n3:Drug
n3:description
A non-narcotic oral antitussive agent.
n3:group
approved
n3:indication
For the treatment of cough.
owl:sameAs
n13:DB08796 n16:DB08796
dcterms:title
Pipazethate
adms:identifier
n8:D05484 n9:21046 n10:DB08796 n17:Pipazetate n18:PA165958415
n3:synonym
Pipazetate
n14:hasConcept
n15:M0065813
n3:IUPAC-Name
n4:271B54BE-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B54C4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B54C3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B54C0-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B54C1-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B54C2-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B54BC-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B54BA-363D-11E5-9242-09173F13E4C5 n4:271B54BD-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B54BB-363D-11E5-9242-09173F13E4C5
n5:hasATCCode
n6:R05DB11
n3:H-Bond-Acceptor-Count
n4:271B54CA-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B54CB-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B54C5-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B54C6-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B54C8-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B54C7-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B54C9-363D-11E5-9242-09173F13E4C5
n3:affectedOrganism
Humans and other mammals
n3:casRegistryNumber
2167-85-3
n3:category
n3:Bioavailability
n4:271B54CF-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B54D1-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B54D2-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B54CE-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B54CD-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B54D0-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B54BF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B54CC-363D-11E5-9242-09173F13E4C5